Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» metabolic disorders
metabolic disorders
Novo Nordisk and Variant set out to find new metabolic treatments, pay communities that share genetic data
Fierce Biotech
Tue, 01/7/25 - 11:37 am
Novo Nordisk
Variant Bio
metabolic disorders
drug discovery
Lilly Plunks Down up to $731M in GPCR Pact with Sosei
BioSpace
Fri, 12/16/22 - 10:27 am
Eli Lilly
Sosei
drug discovery
drug development
diabetes
metabolic disorders
Biosimilars hit a turning point as they expand outside oncology
Clinical Trials Arena
Fri, 12/9/22 - 10:31 am
biosimilars
oncology
immunology
gastroenterology
ophthalmology
Respiratory
dermatology
metabolic disorders
musculoskeletal disorders
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
PR Newswire
Fri, 11/11/22 - 10:32 am
Lipidio Pharmaceuticals
funding
metabolic disorders
1b, or not 1b: FDA hits Viking with clinical hold over mix-up in phase of rare disease trial
Fierce Biotech
Mon, 01/24/22 - 10:19 am
Viking Therapeutics
clinical trials
FDA
VK0214
metabolic disorders
Eli Lilly pens $1.5B biobucks pact with China's Regor for metabolic disease work
Fierce Biotech
Fri, 12/10/21 - 11:05 am
Eli Lilly
China
Regor Therapeutics
metabolic disorders
Combining forces in metabolic disorders
EP Vantage
Mon, 06/28/21 - 10:45 am
Altimmune
obesity
clinical trials
metabolic disorders
Silence Therapeutics Says Collaborating With Astrazeneca On siRNA Therapeutics
Reuters
Wed, 03/25/20 - 10:34 am
Silence Therapeutics
AstraZeneca
siRNA
drug development
cardiovascular disease
renal disease
respiratory disease
metabolic disorders
European rare disease biotech Azafaros grabs $28M early funding round
Fierce Biotech
Thu, 02/6/20 - 10:57 am
Azafaros
metabolic disorders
Magenta Therapeutics presents updated Phase 2 clinical data on MGTA-456 cell therapy
Pharmaceutical Business Review
Fri, 05/10/19 - 10:32 am
Magenta Therapeutics
cell therapy
clinical trials
MGTA-456
inherited metabolic disorders
metabolic disorders
Pfizer’s Metabolic, Rare Disease Segments: Hope for the Future?
Market Realist
Fri, 11/18/16 - 10:06 am
Pfizer
metabolic disorders
rare disease
AstraZeneca’s CVMD Segment: How Did It Perform in 2Q15?
Yahoo/Market Realist
Wed, 08/26/15 - 10:43 am
AstraZeneca
cardiovascular disease
metabolic disorders
Onglyza
Crestor
Brilinta
Genfit signs drug deal with Sanofi, shares surge
Reuters
Thu, 03/17/11 - 10:54 am
Genfit
Sanofi
drug discovery
metabolic disorders